MENU
+Compare
FOLD
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$9.19
Change
+$0.12 (+1.32%)
Capitalization
2.75B

FOLD Amicus Therapeutics Forecast, Technical & Fundamental Analysis

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for FOLD with price predictions
Feb 18, 2025

Aroon Indicator for FOLD shows an upward move is likely

FOLD's Aroon Indicator triggered a bullish signal on February 14, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 193 similar instances where the Aroon Indicator showed a similar pattern. In of the 193 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 13, 2025. You may want to consider a long position or call options on FOLD as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FOLD moved above its 50-day moving average on February 13, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FOLD crossed bullishly above the 50-day moving average on February 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FOLD advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where FOLD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOLD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FOLD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.164) is normal, around the industry mean (12.604). P/E Ratio (0.000) is within average values for comparable stocks, (85.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.581). FOLD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (5.277) is also within normal values, averaging (252.111).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOLD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FOLD is expected to report earnings to fall 87.00% to 1 cents per share on February 19

Amicus Therapeutics FOLD Stock Earnings Reports
Q4'24
Est.
$0.01
Q3'24
Beat
by $0.10
Q2'24
Est.
$-0.05
Q1'24
Beat
by $0.04
Q4'23
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of 10 cents, beating the estimate of 0 cents. With 2.60M shares outstanding, the current market capitalization sits at 2.75B.
A.I. Advisor
published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

FOLD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with ALDX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
+0.82%
ALDX - FOLD
42%
Loosely correlated
+1.85%
DNLI - FOLD
39%
Loosely correlated
+1.97%
PRTA - FOLD
39%
Loosely correlated
-1.83%
RARE - FOLD
36%
Loosely correlated
+2.66%
TECH - FOLD
36%
Loosely correlated
-0.99%
More